Pancreatic Cancer Outcome Highlights via On-Table Adaptive MR guided Radiation
Originally Aired: October 24, 2017
Please join Dr. Parag Parikh, BSE, M.D., Associate Professor of Radiation Oncology and Biomedical Engineering at Washington University in St. Louis, and Dr. Percy Lee, M.D., Associate Professor and Vice Chair of Education for the Department of Radiation Oncology at the David Geffen School of Medicine at UCLA and the UCLA Jonsson Comprehensive Cancer Center as they share their ongoing experience in using MR guided radiation therapy to treat pancreatic cancer.
This presentation includes highlights of significant outcomes and treatment protocols currently used with their patients.
The webinar will compliment their poster published at ASTRO17, “Higher Maximum Biologic Effective Dose Utilizing Adaptive MRI Guided Radiation Therapy Improves Survival of Inoperable Pancreatic Cancer Patients”, which provided a retrospective review of 42 locally-advanced pancreatic cancer patients treated at four institutions:
- Washington University and Siteman Cancer Center at Barnes-Jewish Hospital, St. Louis
- University of California, Los Angeles Health System and Jonsson Comprehensive Cancer Center
- University of Wisconsin Carbone Cancer Center in Madison
- VU University Medical Center in Amsterdam, Netherlands
The study found that stereotactic dosing regimens guided by MR imaging using the MRIdian system and daily online adaptation had led to significantly prolonged patient survival and resulted in favorably low toxicity.
About ViewRay®, Inc
ViewRay®, Inc. (Nasdaq: VRAY) designs, manufactures and markets the MRIdian® radiation therapy system. MRIdian integrates MRI technology, radiation delivery and proprietary software to locate, target and track the position and shape of soft-tissue tumors during radiation. ViewRay believes this combination of enhanced visualization and accuracy will significantly improve outcomes for patients.
ViewRay and MRIdian are registered trademarks of ViewRay, Inc.
David Geffen School of Medicine at UCLA , UCLA Jonsson Comprehensive Cancer Center